Broadfin Capital’s Regulus Therapeutics RGLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q1
Sell
-12,578
Closed -$1.57M 52
2017
Q4
$1.57M Sell
12,578
-23,210
-65% -$2.9M 0.26% 37
2017
Q3
$5.37M Buy
+35,788
New +$5.37M 0.79% 30